CIQ BCR-ABL1 Kit
The CIQ BCR-ABL1 kit is intended for performance monitoring of quantitative BCR-ABL1 transcript analysis for transcripts resulting from e1a2 (minor) and e14a2 (major) translocations.
This kit contains 96 RNAshell® minicapsules to control the performance of 32 quantitative BCR-ABL1 transcript analytical assays.
Each analysis series will contain the patient samples + 3 RNAshell® controls with ratios of BCR-ABL1 versus ABL1 established on the International Scale (%IS) to be close to:
~ 0.1% IS, RNA Low control (B)
~ 1% IS, RNA Medium control (I)
~ 10% IS, RNA High control (H)
RNAshell® technology ensures the stability of the RNAs during transport and storage of the kit at room temperature. It makes measurements more reliable and simplifies laboratory logistics.
- A rack of 96 RNAshell® minicapsules allowing to control 32 series of analyzes, including for each series 1 μg of high, intermediate and low-level control RNA.
- An empty working rack to receive the 3 RNAshell® minicapsules intended to be used for the control of a series of analyzes
- Four portable shellOpener©, each one can be used to open up to 30 minicapsules
- The lot validation certificate by the GBMHM (Group of Molecular Biologists of Malignant Hematologic Diseases)
- The CE-IVD certificate
- The instructions for use
Easy opening of RNAshell® minicapsules thanks to the shellOpener©. Simply add RNase-free water to bring the dehydrated RNA back into solution, then ready for use.